Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- Music Therapy in Sickle Cell Pain Mixed Methods Study: Complete Statistical AnalysisIndependent statistical analysis of Music Therapy in Sickle Cell Pain Mixed Methods Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270060).
- Music Therapy Versus Control for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Music Therapy Versus Control for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03569397).
- Music vs. No Music During Cesarean Delivery on Patient Satisfaction: Complete Statistical AnalysisIndependent statistical analysis of Music vs. No Music During Cesarean Delivery on Patient Satisfaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03412019).
- MV-ZIKA-RSPIndependent statistical analysis of Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04033068).
- MVA-BN-RSV Vaccine Trial: Complete Statistical AnalysisIndependent statistical analysis of MVA-BN-RSV Vaccine Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05238025).
- MVP#1Independent statistical analysis of Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515177).
- My-CRAIndependent statistical analysis of Oral Liquid 13-cis-retinoic Acid (13-CRA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03291080).
- MY-SkillsIndependent statistical analysis of Online Education and Gentle Exercise Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03440320).
- MYCureIndependent statistical analysis of Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MYDAYISIndependent statistical analysis of Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening: primary endpoint results, effect estimate with…
- Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mylan Insulin Aspart Study: Complete Statistical AnalysisIndependent statistical analysis of Mylan Insulin Aspart Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03760068).
- MyMenoPlan: Online Resource for Improving Women’s Menopause Knowledge and Informed Decision-making: Complete Statistical AnalysisIndependent statistical analysis of MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myoc GeneIndependent statistical analysis of Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Myocardial Injury and Quality of Life After COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Myocardial Injury and Quality of Life After COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04794062).
- myOpportunITy2Independent statistical analysis of A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- myOpportunITy3Independent statistical analysis of A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- MyoSure Hysteroscopic Tissue Removal System Registry Study: Complete Statistical AnalysisIndependent statistical analysis of MyoSure Hysteroscopic Tissue Removal System Registry Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01369758).
- MyPathIndependent statistical analysis of Patient-Centered Reproductive Decision Support Tool for Women Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04584294).
- MYTechIndependent statistical analysis of Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- N-3 PUFA and Rheumatoid Arthritis in Korea: Complete Statistical AnalysisIndependent statistical analysis of N-3 PUFA and Rheumatoid Arthritis in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01618019).
- N-Acetyl Cysteine in Pathologic Skin Picking: Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl Cysteine in Pathologic Skin Picking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01063348).
- N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC): Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03759639).
- N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00248625).
- N30-005Independent statistical analysis of Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- N6 Input Processing in Traditional CI Recipients: Complete Statistical AnalysisIndependent statistical analysis of N6 Input Processing in Traditional CI Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02239263).
- Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: Complete Statistical AnalysisIndependent statistical analysis of Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01893801).
- Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence…
- Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: primary endpoint results, effect estimate with…
- Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nabilone in Cannabis Users With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Nabilone in Cannabis Users With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03251326).
- NABIS:HIIRIndependent statistical analysis of Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178711).
- NACIndependent statistical analysis of Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NACIndependent statistical analysis of N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02791945).
- NAC cold coughIndependent statistical analysis of Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NAC MJ PilotIndependent statistical analysis of An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00542750).
- NAD+ Precursor Supplementation in Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of NAD+ Precursor Supplementation in Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04817111).
- NAFLDIndependent statistical analysis of Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NAFLDIndependent statistical analysis of Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Naltrexone for Impulse Control Disorders in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone for Impulse Control Disorders in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052831).
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NAMESIndependent statistical analysis of Northwestern University and Access Community Health Network Medication Education Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578577).
- NAPSIndependent statistical analysis of Nattokinase Atherothrombotic Prevention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080520).
- NARLALIndependent statistical analysis of Navelbine And Radiotherapy in Locally Advanced Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00887783).
- Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: Complete Statistical AnalysisIndependent statistical analysis of Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…